Failure to Operationalize Antibiotic Stewardship and Document Culture-Based Treatment
Summary
The facility failed to implement and operationalize a comprehensive Antibiotic Stewardship Program, including documentation and treatment review for residents receiving antimicrobial therapy. During interview and record review, the Infection Control RN stated the facility used McGeer criteria, but the monthly antibiotic line listings and monthly analysis did not specify whether infections being treated met those criteria. The Infection Control RN also stated that the computer system identified whether an infection met McGeer criteria when entered, but she was not sure whether any listed infections did not meet criteria, and the antibiotic use report provided to the prescriber was only a list of antibiotics prescribed during the month. For one resident, the October 2024 line list showed a healthcare-associated UTI with cephalexin treatment, but the causative organism was not identified. The Infection Control RN stated she did not know whether the infection met McGeer criteria. When asked about the urinalysis and culture, she stated there was no growth, yet the antibiotic was continued, and she could not provide documentation that the antibiotic use was addressed with the health care provider. The same resident was also listed for a new infection in October and was treated with daptomycin for MRSA involving a dialysis port, with the line list noting that the resident was to receive IV vancomycin and daptomycin at dialysis. The Infection Control RN stated the wound culture and causative organism were most likely in hospital records and were not readily available in the facility's infection control tracking. For another resident, a urology visit note documented hematuria and UTI with an order for Macrobid 100 mg twice daily for 30 capsules, and the MAR showed Macrobid was given for 15 days for UTI. The facility's antibiotic line listing identified the organism as 'Null.' The Infection Control RN stated the urologist office did not identify an organism and the facility did not perform a culture and sensitivity. For a third resident, progress notes documented a positive UA and a new order for Macrobid 100 mg twice daily for 5 days, but no organism was identified and no culture and sensitivity was found in the medical record. The resident later complained of loose stools, which were documented as a side effect of antibiotic medication. The Infection Control RN stated the antibiotic was started with no organism known and that there were no risk versus benefit statements for residents because she was unsure what to do when antibiotic use occurred without an identified organism. A fourth resident was sent to the ER for chest pain and shortness of breath and returned with a UTI diagnosis and antibiotic therapy. The Infection Control RN stated the organism still needed to be obtained from the ER or hospital, and no urine culture or sensitivity was found in the medical record at the time of review. The resident's MAR showed cephalexin for UTI, later changed to ciprofloxacin. The Infection Control RN acknowledged that treating the wrong organism could create antibiotic-resistant organisms. The facility policy stated that the Antibiotic Stewardship Program was intended to optimize infection treatment while reducing adverse events associated with antibiotic use, and that laboratory testing should follow current standards of practice and narrow-spectrum antibiotics should be used whenever possible.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.